Dowling & Yahnke’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,098
Closed -$207K 381
2022
Q2
$207K Sell
4,098
-24
-0.6% -$1.31K 0.01% 352
2022
Q1
$251K Hold
4,122
0.01% 336
2021
Q4
$271K Hold
4,122
0.01% 331
2021
Q3
$259K Buy
+4,122
New +$263K 0.01% 326
2020
Q1
Sell
-690
Closed -$30K 337
2019
Q4
$30K Buy
+690
New +$29K ﹤0.01% 329

Other funds holding IHI

Dowling & Yahnke's IHI Position: Q3 2022 in Review

Dowling & Yahnke sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 4,098 shares — an estimated $207K sold.

Dowling & Yahnke first reported a position in IHI in Q4 2019 and held it in 5 quarters. The position peaked at $271K in Q4 2021. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

  • Dowling & Yahnke reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
  • Dowling & Yahnke sold 4,098 iShares US Medical Devices ETF shares in Q3 2022, an estimated $207K.
  • Dowling & Yahnke first reported a position in iShares US Medical Devices ETF in Q4 2019 and held it in 5 quarters.
  • Dowling & Yahnke's iShares US Medical Devices ETF position peaked at $271K in Q4 2021.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.